1. Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms. Issue 18 (December 2015) Authors: Johnson, Douglas B.; Menzies, Alexander M.; Zimmer, Lisa; Eroglu, Zeynep; Ye, Fei; Zhao, Shilin; Rizos, Helen; Sucker, Antje; Scolyer, Richard A.; Gutzmer, Ralf; Gogas, Helen; Kefford, Richard F.; Thompson, John F.; Becker, Jürgen C.; Berking, Carola; Egberts, Friederike; Loquai, Carmen; Goldinge... Journal: European journal of cancer Issue: Volume 51:Issue 18(2015:Dec.) Page Start: 2792 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Control of NF‐kB activity in human melanoma by bromodomain and extra‐terminal protein inhibitor I‐BET151. (3rd July 2014) Authors: Gallagher, Stuart J.; Mijatov, Branka; Gunatilake, Dilini; Gowrishankar, Kavitha; Tiffen, Jessamy; James, Wilmott; Jin, Lei; Pupo, Gulietta; Cullinane, Carleen; McArthur, Grant A.; Tummino, Peter J.; Rizos, Helen; Hersey, Peter Journal: Pigment cell & melanoma research Issue: Volume 27:Number 6(2014:Nov.) Page Start: 1126 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Co‐targeting bromodomain and extra‐terminal proteins and MCL1 induces synergistic cell death in melanoma. Issue 8 (24th April 2020) Authors: Tseng, Hsin‐Yi; Dreyer, Jan; Emran, Abdullah Al; Gunatilake, Dilini; Pirozyan, Mehdi; Cullinane, Carleen; Dutton‐Regester, Ken; Rizos, Helen; Hayward, Nicholas K.; McArthur, Grant; Hersey, Peter; Tiffen, Jessamy; Gallagher, Stuart Journal: International journal of cancer Issue: Volume 147:Issue 8(2020) Page Start: 2176 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Differential activity of MEK and ERK inhibitors in BRAF inhibitor resistant melanoma1. Issue 3 (15th January 2014) Authors: Carlino, Matteo S.; Todd, Jason R.; Gowrishankar, Kavitha; Mijatov, Branka; Pupo, Gulietta M.; Fung, Carina; Snoyman, Stephanie; Hersey, Peter; Long, Georgina V.; Kefford, Richard F.; Rizos, Helen Journal: Molecular oncology Issue: Volume 8:Issue 3(2014:May) Page Start: 544 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Effects of BRAF inhibitors on human melanoma tissue before treatment, early during treatment, and on progression. (3rd May 2013) Authors: Long, Georgina V.; Wilmott, James S.; Haydu, Lauren E.; Tembe, Varsha; Sharma, Raghwa; Rizos, Helen; Thompson, John F.; Howle, Julie; Scolyer, Richard A.; Kefford, Richard F. Journal: Pigment cell & melanoma research Issue: Volume 26:Number 4(2013:Jul.) Page Start: 499 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. HDAC inhibitors restore BRAF‐inhibitor sensitivity by altering PI3K and survival signalling in a subset of melanoma. Issue 9 (20th December 2017) Authors: Gallagher, Stuart J.; Gunatilake, Dilini; Beaumont, Kimberley A.; Sharp, Danae M.; Tiffen, Jessamy C.; Heinemann, Anja; Weninger, Wolfgang; Haass, Nikolas K.; Wilmott, James S.; Madore, Jason; Ferguson, Peter M.; Rizos, Helen; Hersey, Peter Journal: International journal of cancer Issue: Volume 142:Issue 9(2018) Page Start: 1926 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Integrated molecular and immunophenotypic analysis of NK cells in anti-PD-1 treated metastatic melanoma patients. (1st February 2019) Authors: Lee, Hansol; Quek, Camelia; Silva, Ines; Tasker, Annie; Batten, Marcel; Rizos, Helen; Lim, Su Yin; Nur Gide, Tuba; Shang, Ping; Attrill, Grace H.; Madore, Jason; Edwards, Jarem; Carlino, Matteo S.; Guminski, Alexander; Saw, Robyn P.M.; Thompson, John F.; Ferguson, Peter M.; Palendira, Umaimaintha... Journal: Oncoimmunology Issue: Volume 8:Number 2(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Mechanisms and strategies to overcome resistance to molecularly targeted therapy for melanoma. (1st June 2017) Authors: Lim, Su Yin; Menzies, Alexander M.; Rizos, Helen Journal: Cancer Issue: Volume 123(2017)Supplement S11 Page Start: 2118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Melanocyte reprogramming requires chromatin and transcription remodelling. (3rd March 2016) Authors: Welsh, Sarah J.; Rizos, Helen Journal: Pigment cell & melanoma research Issue: Volume 29:Number 3(2016:May) Page Start: 260 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Mitogen‐activated protein kinase dependency in BRAF/RAS wild‐type melanoma: A rationale for combination inhibitors. (25th September 2019) Authors: Ming, Zizhen; Lim, Su Yin; Kefford, Richard F.; Rizos, Helen Journal: Pigment cell & melanoma research Issue: Volume 33:Number 2(2020) Page Start: 345 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗